Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line Dear Editor,
Dear Editor,
We report a novel follow-up observation pertaining to "An in vivo patient-derived model of endogenous IDH1-mutant glioma," which was recently published in Neuro-Oncology. 1 Since publication, we have observed the gradual and repeated loss of the wild-type IDH1 allele in vitro with retention of the mutant allele. Sequencing of IDH1 exon 4 from 3 independent late passage cultures showed homozygosity for the R132H allele (mut/-), whereas both mutant and wild-type alleles were present in the original line (mut/wt) and tumor (Fig. 1A) . In addition, a decreased copy number was seen at the IDH locus, consistent with loss of the IDH1 wild-type allele (Fig. 1B) . The American Type Culture Collection (ATCC) has independently observed this phenomenon in BT142. The ATCC is preparing to distribute the BT142 mut/-, 2 while we test conditions that best preserve the heterozygous phenotype.
The loss of the wild-type allele has been reported in vivo in patients and has been shown to be similar to phenotypically wild-type IDH, resulting in decreased 2-hydroxyglutarate production, 3, 4 also observed in the BT142 mut/-line. This unforeseen change leading to a second cell line will be valuable for comparisons of the implications of mutant and wild-type IDH phenotypes on proliferation, tumorigenicity, and therapeutic resistance in a syngeneic setting.
Methods
Sequencing for IDH1 was performed as previously described. 1 The TaqMan Copy Number Assay (Applied Biosystems) was used to assess copy-number variations. Briefly, genomic DNA was extracted using the DNeasy kit (Qiagen) and quantified using UV absorbance (A260/ A280 ratio .1.7). The genomic DNA samples were diluted to 5 ng/mL in nuclease-free water; 20 ng of genomic DNA was mixed with the IDH1 TaqMan Copy Number Assay and the RNase P Reference Assay in a PCR plate, and quantitative real-time PCR was performed according to the manufacturer's instructions. The manufacturer's software, Copy Caller, was used for analysis. 
